BioCentury
ARTICLE | Company News

ImmunoCellular management update

December 10, 2012 8:00 AM UTC

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Woodland Hills, Calif. Business: Cancer Hired: Andrew Gengos as president, CEO and a director, formerly president and CEO of Neuraltus Pharmaceuticals ...